3 results match your criteria: "S-302 Medical Center[Affiliation]"

Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit.

Pediatrics

July 2006

Department of Pediatrics, Pediatric Endocrinology and Diabetes, Stanford University, S-302 Medical Center, Stanford, California 94305-5208, USA.

Objective: We evaluated retrospectively plasma glucose levels and the degree of hypoglycemia, hyperglycemia, and glucose variability in a PICU and then assessed their association with hospital length of stay and mortality rates.

Methods: Electronic medical records at the Packard Children's Hospital at Stanford University were reviewed retrospectively for all PICU admissions between March 1, 2003, and March 31, 2004. Patients with a known diagnosis of diabetes mellitus were excluded.

View Article and Find Full Text PDF

Prevention of type 1a diabetes mellitus*.

Pediatr Diabetes

March 2001

Division of Pediatric Endocrinology and Diabetes, S-302 Medical Center, Stanford, CA 94305-5208, USA.

Type 1 diabetes begins with the progressive autoimmune mediated destruction of the insulin-producing beta cells. When sufficient beta cell function is lost, the endocrine phase, characterized by insulin deficiency and hyperglycemia, supervenes. While a genetic predisposition to diabetes is an important precondition, most believe an environmental factor or factors serve as the trigger for initiating this process.

View Article and Find Full Text PDF

Endocrinology of growth and growth factors.

Connect Tissue Res

March 2005

Stanford University, S-302 Medical Center, Stanford, CA 94305, USA.

This review discusses normal growth patterns and the appropriate use of preprinted growth curves. The important roles of thyroid and growth hormone in the modulation of growth are delineated. I present an approach to the evaluation and proper management of children and adolescents with short stature and poor growth.

View Article and Find Full Text PDF